TU/e Sensing Team (T.E.S.T.)

What TU/e Sensing Team (T.E.S.T.) does

T.E.S.T. (TU Eindhoven Sensing Team) is a multidisciplinary student team founded in 2016 at Eindhoven University of Technology in Eindhoven, Netherlands, that competes in the annual international SensUs Competition for medical biosensor innovation. The team comprises 8 bachelor and master students from Biomedical Engineering, Data Science, and Chemical Engineering & Chemistry, organized into a Detection subteam (electronics and physical components) and an Assay subteam (chemical and biological sensing elements). Each year, from November to August, the team designs, builds, and presents a working biosensor prototype targeting a specific disease biomarker; for 2025, the focus is a continuous creatinine biosensor for kidney failure detection, following a 2024 creatinine iteration and earlier work on NT-proBNP (2017), vancomycin (2018), adalimumab (2019), valproate (2020), hemagglutinin (2021), IL-6 (2022), and GFAP (2023).

Technically, the platform is an integrated biosensor combining custom optical and electronic detection hardware (with components supplied by partners such as Thorlabs, Chroma, Neways, and RS Components) with chemical/biological assay chemistry (supported by Merck, Antibodies-online, Promega, Bio-Rad, Thermo Fisher, Rockland, and Randox). The current product emphasizes continuous measurement rather than single-shot detection, an evolution consistent with the team's stated ambition of developing "efficient, affordable and easy-to-use" biosensors with translational commercial potential. Past competition results include the SensUs 2021 Translational Potential Award and the SensUs 2022 Distributed Testing Event win plus Translational Potential runner-up.

T.E.S.T. is structured as a non-commercial, non-profit student organization registered with the Dutch Chamber of Commerce (KvK: 66635373) and does not sell products or services. Its revenue model consists entirely of sponsorship and in-kind contributions from a broad corporate and institutional partner base that has expanded from 2016 founding partners to roughly 25+ named partners by 2025, with Eindhoven University of Technology, Innospace (TUE Innovation Space), Merck, Thorlabs, Chroma, and Onera Health as the current core set. Pricing is not applicable as no commercial product is offered; go-to-market is event-driven, centered on the end-of-August SensUs Competition. The Market Potential and External Affairs functions signal an intent to explore commercial translation, but no commercial entity or revenue has been disclosed.

Name

TU/e Sensing Team (T.E.S.T.)

Legal name

T.E.S.T. Team

Website

https://tuetest.nl

Company type

Private

Founded year

2016

Operating status

Operating

Headcount range

1–10 employees

Short description

T.E.S.T. is a student team at Eindhoven University of Technology that designs and builds a new medical biosensor prototype each year to compete in the international SensUs Competition, with the 2025 focus on a continuous creatinine biosensor for kidney failure detection. It is non-commercial and funded by corporate and academic sponsors.

Ownership category

akta.pro rank

Product category

Medical Biosensors

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714), Analytical Laboratory Instrument Manufacturing (334516), Scientific Research and Development Services (5417)

SIC

Laboratory Analytical Instruments (3826)

akta.pro primary industry

Biosensors & Lab-on-Chip (BioMEMS) (HDAHALAK)

akta.pro secondary industries

Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes) (HLAGAIAI), Proteomics & Biomarker Analytical Testing (HLAGADAG)

Keywords

• Medical biosensor development
• Biomarker detection devices
• Student research team
• Diagnostic biosensors
• Point-of-care sensors

Headquarters

HQ city

Eindhoven

HQ country

Netherlands

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Operations, Supply Chain, Marketing or Sales, Infrastructure

Revenue model

1. Sponsorship and Partnership Funding: The team operates as a student organization funded by corporate sponsors and partners who provide financial and material support in exchange for association with the team and its innovation activities in biosensor development.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

T.E.S.T. is a multidisciplinary student team from Eindhoven University of Technology that designs and prototypes a new medical biosensor every year for the international SensUs Competition. Each biosensor targets a specific disease biomarker (creatinine for kidney failure in 2025, with past iterations on hemagglutinin, Interleukin-6, GFAP and others) and is built by two subteams: an Assay subteam handling chemical/biological recognition elements and a Detection subteam handling the electronics and optical readout. The outputs are working biosensor prototypes presented at the competition, with explicit translational design intent for the commercial diagnostic market.

Product overview

T.E.S.T. operates as a single-product company developing one biosensor platform annually for the SensUs competition. Each year, the team redesigns and builds a new biosensor prototype targeting a specific biomarker relevant to a disease or medical condition. The current product is a continuous creatinine biosensor (creatinine being a key biomarker for kidney failure). The annual biosensor follows a two-subteam structure: the Detection team handles electronics and hardware components, while the Assay team develops the chemical/biological sensing elements. Both subteams converge to produce an integrated, working biosensor prototype with translational commercial potential.

Differentiator

Problem solved

Functional benefit

Products and services

• Continuous Creatinine Biosensor (2025) A continuous biosensor device for detecting creatinine, a biomarker for kidney failure. Built by multidisciplinary student teams from Eindhoven University of Technology, it integrates an Assay subteam (chemical/biological recognition) with a Detection subteam (electronics/optical readout) into a working prototype with translational design intent for the commercial diagnostic market.

Quantifiable outcome

• Winner of SensUs 2022 - Distributed Testing Event & Runner-up Translational Potential
• +1 more outcomes

Segments1 record

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature2 records

Partnerships

Eleven partnerships are on record, tiered core and minor.

• Eindhoven University of Technology (TU/e)coreStrategic or Co-development Partner · 1 January 2025The parent institution providing the team structure, facilities, and academic oversight for T.E.S.T.'s biosensor development activities.
• Innospace (TUE Innovation Space)coreTechnology or Integration · 1 January 2025Innovation space at TU/e that supports student teams and startups with resources for developing new technologies.
• Antibodies-onlineminorOthers · 1 January 2025Partner providing antibody-related products and search services, supporting the assay development component of biosensor research.
• ThorlabscoreTechnology or Integration · 1 January 2025Optical equipment manufacturer providing components for the detection systems in the biosensor development.
• MerckcoreStrategic or Co-development Partner · 1 January 2025Global science and technology company providing chemical and biological materials for biosensor assay development. Partner for 2024 and 2025.
• YERminorChannel Partner/ Reseller/ Distributor · 1 January 2024Recruitment and staffing company that may support the team with connections to industry professionals.
• RocklandminorOthers · 1 January 2024Provider of antibodies and immunological products for research applications.
• ALTENminorStrategic or Co-development Partner · 1 January 2023Engineering and technology consulting firm supporting the team's technical development.
• DSMminorStrategic or Co-development Partner · 1 January 2018Global science-based company active in health, nutrition, and materials providing expertise and resources.
• UFEminorStrategic or Co-development Partner · 1 January 2017University Fund Eindhoven supporting student initiatives and innovation projects.
• High Tech Campus EindhovenminorStrategic or Co-development Partner · 1 January 2017Technology innovation campus providing ecosystem connections and potential resources for the team.

Scale indicators2 records

Recent moves6 records

Expansion highlights4 records

Broad incumbents

• Siemens Healthineers: Operates clinical chemistry, immunoassay, and specialty diagnostic testing platforms covering biomarkers such as NT-proBNP and IL-6 that T.E.S.T. has also targeted. Comparable as the commercial benchmark the team's biosensor concepts are measured against.
• Roche Diagnostics: Major in-vitro diagnostics provider with extensive assay menus, including cardiac, infectious disease, and inflammatory markers overlapping T.E.S.T.'s biomarker interests (NT-proBNP, IL-6). Comparable as the regulated, scaled market player whose existence frames the translational ambition of T.E.S.T.'s prototypes.
• Abbott Diagnostics: Global diagnostics incumbent with broad biomarker menus including creatinine and IL-6 assays used in hospital and point-of-care settings. Comparable to T.E.S.T. as the established commercial counterpart whose products the team's prototypes aim to complement or precede.
• Philips: Diversified health technology company with significant diagnostics, patient monitoring, and biomedical engineering activities centered in the Eindhoven / Brainport region. Comparable to T.E.S.T. as a major local healthcare/biomedical player whose sensor and monitoring businesses frame the regional opportunity for the team's technology.

Direct peers

• bioMérieux: Specialist in vitro diagnostics company focused on clinical and industrial microbiology, immunoassays, and molecular diagnostics. Comparable to T.E.S.T. as a diagnostics-focused organization developing assays for clinically relevant biomarkers and infectious disease markers similar to IL-6 and hemagglutinin.
• Cytiva: Provider of life-science tools, bioprocess solutions, and biosensor/diagnostic assay development technologies used in research and clinical labs. Comparable to T.E.S.T. as a supplier of the assay development tools the team uses in its biosensor work.
• Bio-Rad Laboratories: Life-science research and clinical diagnostics company with strong portfolios in immunoassays, protein detection, and lab instrumentation. Comparable to T.E.S.T. as both a diagnostics/reagent supplier and a documented T.E.S.T. partner (since 2019).
• Randox Laboratories: Diagnostics and life-science company supplying clinical chemistry reagents, immunoassays, and biosensor-related research tools. Directly comparable to T.E.S.T. as a diagnostics specialist and an actual T.E.S.T. partner (since 2016) supporting biosensor assay development.
• QuidelOrtho: Specialist diagnostics company with immunoassay and molecular testing products, including infectious disease markers such as influenza. Comparable to T.E.S.T. as a diagnostics specialist whose product portfolio overlaps with the team's hemagglutinin (Influenza A) and IL-6 (sepsis) targets.
• Dexcom: Continuous biosensor company commercializing wearable glucose monitors and exploring additional analytes. Comparable to T.E.S.T. as a continuous-monitoring biosensor specialist, directly relevant given the team's 2024-2025 focus on a continuous creatinine sensor.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/tuesensingteam

Revenue estimate

Valuation estimate

Number of profiles

Profiles8 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about TU/e Sensing Team (T.E.S.T.)